 At the same time, Amazon's foray is widely expected to disrupt the industry, prompting drug chains to beef up their businesses. Backed by private equity firm Cerberus Capital Management, Albertsons hopes the deal will help it become a formidable competitor to CVS Corp and Walgreens , and give its private equity owners a way to exit their decade-long investment in the grocer. Cerberus first took a stake in Albertsons in 2006 and scaled it through acquisitions including that of Safeway in 2014.
|